High-level delegation visits Nigeria, urges commitments from government
As Nigeria intensifies efforts to halt the transmission of type 2 variant poliovirus, a high-level delegation from the Global Polio Eradication Initiative (GPEI), visited Abuja, Nigeria, 27-28 February 2025. During the visit, government, traditional leaders, and partners renewed their commitment to overcome remaining challenges to end polio in Nigeria.
The visit, conducted by the Polio Oversight Board (POB), which is the highest decision-making body of GPEI, focused on reviewing progress, addressing challenges such as insecurity and vaccine misinformation, and mobilizing increased domestic and international support for polio eradication.
Led by Dr Chris Elias, Chair of the POB, the delegation engaged in conversations with Nigeria's government and the highest traditional leader, the Sultan of Sokoto, to emphasize the need for renewed country leadership and ownership at all levels of government in the effort to stop the ongoing transmission of type 2 variant poliovirus.
Other members of the delegation included Dr Chikwe Ihekweazu, Acting WHO Regional Director for Africa, Mr Gilles Fagninou, UNICEF's Regional Director for West and Central Africa, Mr Mike McGovern, Chair of Rotary International PolioPlus Committee, Mr Derrick Sim, Interim Chief Vaccine Programmes&Markets Officer, Gavi, the Vaccine Alliance; Mr. Massimo De Luca, Head of Cooperation at the Delegation of the European Union to the Federal Republic of Nigeria and ECOWAS and GPEI Donor Representative.
In Abuja, the delegation met with Prof Muhammad Ali Pate, the Coordinating Minister of Health and Social Welfare, who emphasized the country's longstanding commitment to polio eradication and underscored that further dedication across the country is necessary to implement corrective measures and stop transmission for good. The POB delegation also met His Royale Highness Abubakar, Umar Suleiman, Mai Bade, representing the Sultan of Sokoto, who reaffirmed Nigeria's steadfast commitment to polio eradication and routine immunization strengthening.
Additionally, the delegation met with Dr Muyi Aina, Executive Director and CEO of the National Primary Health Care Development Agency, and leadership from the National Emergency Operations Center. They assessed the current epidemiology of the virus and discussed the recommendations from the 42nd Expert Review Committee (ERC) on Polio Eradication and Routine Immunization in Nigeria.
The ERC, a technical body composed of experts who regularly assess the progress of a country's polio eradication programme, met in Abuja on 29-30 January 2025 and gave a series of recommendations. To close immunity gaps and end polio transmission, the ERC urged greater political leadership, calling for active engagement of government officials and stronger accountability measures. The ERC recommended surveillance efforts and campaign quality must be improved through proven strategies to ensure targeted vaccine coverage. To enhance operations, the ERC recommended digitalizing vaccine tracking, strengthening cold chain logistics and ensuring timely fund disbursements. Additionally, the ERC recommended routine immunization must be strengthened through integration with polio campaigns and by deploying effective social mobilization strategies to counter misinformation and vaccine hesitancy.
Throughout 2023-2024, type 2 variant poliovirus transmission levels were static despite tremendous efforts at all levels to reach every under-5 child with polio vaccines in the states that are affected by variant poliovirus. As of 15 February 2025, there were 94 confirmed polio affected children across 15 States during 2024. No type 2 variant poliovirus cases have been detected in Nigeria so far in 2025.
The POB delegation underscored that renewed commitment from stakeholders at all levels of the country's robust polio eradication programme is critical to stopping the type 2 variant poliovirus from spreading within Nigeria and across neighbouring countries. Delegates further emphasized the need to accelerate the strengthening of routine immunization systems, given that optimal routine immunization coverage is key to breaking the ongoing transmission of type 2 variant poliovirus.
Together with the government, the delegation agreed that rapid progress can be possible with significant efforts coordinating across states and federal ministries. Nigerian leaders reaffirmed their commitment to bolstering polio outbreak response activities and routine immunization to protect all children against polio.
Distributed by APO Group on behalf of World Health Organization (WHO) - Nigeria.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
20-05-2025
- Zawya
Outbreak of variant type 1 polio in Madagascar declared over
Madagascar has successfully halted the transmission of variant poliovirus type 1, following recommendations from a rigorous, independent Outbreak Response Assessment (OBRA) to declare the outbreak closed. This achievement marks a major milestone in the country's ongoing efforts towards polio eradication. The outbreak, which started in 2020, posed a serious public health threat, particularly to under 5 children but also to unvaccinated adults. In response, the government – through the Emergencies Operations Centre – in collaboration with the Global Polio Eradication Initiative (GPEI), swiftly launched a series of emergency vaccination campaigns. This effort, backed by strong political commitment from the highest levels, including the President and First Lady of Madagascar, successfully reached over 19 million people with life-saving polio vaccines. As a result, no new detections have been reported since September 2023. Meeting the criteria for outbreak closure is a major achievement. For the certification to be met, a country must ensure high population immunity, strong surveillance performance (evidence that no transmission was missed), and at least 12 consecutive months without poliovirus detection (either in humans or environmental – sewage/wastewater). 'The progress made in recent years in the immunization and eradication of polio is a hopeful sign. Today, polio is finally eradicated. Together, we have proved that it is possible to overcome limits and build lasting change. Let's continue to act, raise awareness and join forces to give every child a healthy future', said H.E. Mrs Mialy Rajoelina, The First Lady of Madagascar and immunization ambassador. At the outbreak's peak in September 2023, a total of 287 cases had been confirmed, including 45 cases of acute flaccid paralysis and 44 community cases, 198 positive environmental surveillance detections in wastewater. Key to halting polio transmission in Madagascar was the country's intensified surveillance system, which enabled swift detection of poliovirus in both human cases and environmental samples. Enhanced case investigation, community engagement, and innovative vaccination strategies, including house-to-house immunization efforts, were instrumental in stopping the spread. Cases were spread across 30 districts in the country's 13 regions and two paralytic cases were reported in adults in January 2023, which placed the country in a unique position that required innovative responses. Four large-scale vaccination campaigns were carried out in 2023, enabling Madagascar to reach 95% vaccination coverage which was pivotal in stopping the transmission and closing the polio outbreak. 'This success demonstrates that with political will, strong partnerships, and community involvement, polio outbreaks can be swiftly controlled. We must now sustain these efforts to prevent any future resurgence,' said Dr Chikwe Ihekweazu, Acting WHO Regional Director for Africa. Health authorities, supported by GAVI, Rotary, UNICEF, WHO and the Gates Foundation, continue to strengthen routine immunization, enhance surveillance, and maintain high-quality outbreak preparedness measures to mitigate the risk of future polio re-emergence, and other vaccine-preventable diseases. 'This achievement is due to strong collaboration of the government, partners and the health workers who worked tirelessly in the frontlines,' said Etleva Kadilli, UNICEF Regional Director for Eastern and Southern Africa. 'Madagascar offers a beacon of hope for polio eradication efforts across Africa, but we must remain vigilant to ensure no further outbreaks occur. Immunization is a child's fundamental right, no matter where they are.' GPEI partners have reaffirmed their commitment to supporting Madagascar in sustaining polio-free status and boosting overall immunization coverage. 'The end of this outbreak is a testament to what's possible when we strengthen routine immunization and expand vaccination coverage" said Thabani Maphosa, Gavi's Chief Country Deliver Officer. "By reaching even the most marginalized communities, we ensure no child is left behind. Continued collaboration across all sectors—government, civil society, and international partners—is essential to maintain this progress and close the immunization gap for zero-dose and under-vaccinated children." The dedication of Rotarians on the ground was also critical: "This is a proud moment for Madagascar. The closure of the outbreak represents the hard work of thousands of frontline workers, volunteers, and our national health teams who never gave up on protecting our children" said Haingo Ranoharisoa, Rotary National PolioPlus Committee Chair for Madagascar. The successful closure of this outbreak serves as a testament to the power of collective action in protecting children from preventable diseases. Distributed by APO Group on behalf of World Health Organization (WHO) - Madagascar.
Zawya
29-04-2025
- Zawya
Health Cabinet Secretary (CS) Hon. Aden Duale Hosts World Health Organization (WHO) Africa Acting Regional Director for Bilateral Talks
Health Cabinet Secretary Hon. Aden Duale today held bilateral discussions with the World Health Organization (WHO) Acting Regional Director for Africa, Dr. Chikwe Ihekweazu, who paid him a courtesy call at his office. The talks focused on sustainable responses to Kenya's multiple and complex public health emergencies, including Mpox, Cholera, Kala-azar, Polio, and Measles, which continue to exert pressure on the healthcare system. The meeting also reviewed progress on the operationalization of the Kenya National Public Health Institute (NPHI), a key body coordinating disease surveillance, emergency preparedness, and response. WHO reaffirmed its commitment to support the NPHI in alignment with its public health mandate. Hon. Duale appreciated WHO's longstanding support to Kenya's health sector and called for enhanced collaboration in emergency logistics and supplies, health worker training and capacity building, as well as community-based surveillance and risk communication. These areas are crucial to advancing the Universal Health Coverage agenda. The CS was joined by Principal Secretary for Medical Services Dr. Ouma Oluga, Director General for Health Dr. Patrick Amoth, Ag. DG, NPHI Dr Maureen Kamene and Dr. Stephen K. Muleshe, Senior Deputy Director, Office of International Health Relations, MOH. Distributed by APO Group on behalf of Ministry of Health, Kenya.
Zawya
26-04-2025
- Zawya
Uganda declares end of Ebola outbreak
Uganda today declared the end of the Ebola disease outbreak, less than three months after the virus was confirmed in the capital Kampala. During this outbreak, 14 cases, 12 confirmed and two not confirmed through laboratory tests (probable), were reported. Four deaths, two confirmed and two probable, occurred. Ten people recovered from the infection. A total of 534 people were identified as having been in contact with the confirmed and probable cases and were closely monitored. The last confirmed patient was discharged on 15 March 2025, triggering the 42-day countdown to officially declare the end of the outbreak, in line with World Health Organization (WHO) guidelines. This was Uganda's second Ebola outbreak in less than three years. It was confirmed on 30 January 2025. The country's long-standing experience in managing outbreaks enabled a fast, coordinated, and effective response. With support from WHO and partners, the Ministry of Health activated national coordination structures, deployed rapid response teams, strengthened surveillance systems and established treatment units. Border health measures, particularly in Kampala and at points of entry, were reinforced to prevent cross-border transmission. WHO mobilized more than 130 national and international staff to support the response in the areas of case investigation, contact tracing, laboratory diagnostics, and case management. More than 1500 samples were tested with WHO providing logistics, training and quality assurance to ensure biosafety. WHO also facilitated the deployment of Emergency Medical Teams and anthropologists to reduce stigma, build trust and work with affected communities, which was critical in driving behaviour change. 'This outbreak challenged us in new ways. It touched both urban and rural communities across the country and unfolded against the backdrop of significant global funding constraints,' said Dr Chikwe Ihekweazu, Acting WHO Regional Director for Africa. The response demonstrated Uganda's long-standing leadership in tackling public health emergencies. As WHO, we are extremely proud to have supported these efforts every step of the way.' The Ebola strain that has been contained in Uganda is of the Sudan virus disease (SVD) subtype. This strain is a severe, often fatal illness affecting humans and other primates. In past outbreaks, SVD killed 4 in 10 of the people infected. Despite the absence of licensed countermeasures against this species of Ebola, candidate vaccines are in various phases of clinical trials. Within four days of the government's declaration of the outbreak, a randomized clinical trial for vaccine safety and efficacy using the ring vaccination approach was launched. In addition, the administration of Remdesivir treatment under the Monitored Emergency Use of Unregistered and Experimental Interventions (MEURI) protocol was initiated. 'Uganda's leadership and resilience were crucial in containing this outbreak,' said Dr Kasonde Mwinga, WHO Representative in Uganda. From day one, WHO worked hand-in-hand with the Ministry of Health, deploying expertise, providing essential supplies, and ensuring every suspected case was investigated. The people of Uganda have shown extraordinary resolve.' Although the outbreak is over, the Ministry of Health, with continued support from WHO and partners, will continue investing in surveillance, survivor care, and preparedness to ensure Uganda remains safe. Distributed by APO Group on behalf of World Health Organization - Uganda.
